维康药业 (300878.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(维康药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 432,001,715.94316,438,664.65195,738,788.54531,291,689.13474,349,508.65295,623,350.52183,784,056.82
 营业利润(元) 94,196,503.5073,893,086.8133,039,458.7759,452,370.75112,894,059.6866,049,707.5026,209,232.01
 利润总额(元) 89,088,477.4773,363,766.4632,631,990.6557,750,952.35112,886,699.4466,095,590.0626,301,735.68
 净利润(元) 70,873,328.9465,525,522.3528,017,798.7945,120,376.3294,643,387.9257,521,230.3923,128,425.85
 归属于母公司股东的净利润(元) 69,350,633.9964,620,653.8927,526,041.9344,444,260.1493,930,944.6156,985,730.4822,919,976.17
盈利能力:
 销售毛利率(%) 58.1455.5545.7558.5763.4760.9851.90
 销售净利率(%) 16.4120.7114.318.4919.9519.4612.58
 净资产收益率(%) 4.764.501.93----
 总资产报酬率ROA(%) 4.854.141.82----
 投入资本回报率ROIC(%) 3.833.631.552.805.953.801.55
营运能力:
 存货周转率(次) 1.001.130.86----
 应收账款周转率(次) 1.170.850.53----
 总资产周转率(次) 0.220.170.11----
偿债能力:
 资产负债率(%) 28.7727.1428.7126.2419.5716.5316.21
 股东权益比率(%) 70.4072.1970.6473.0780.2283.2683.60
 已获利息倍数(倍) 18.0521.5626.7118.3775.6397.91439.96
 流动比率 2.302.412.142.182.913.553.73
 速动比率 1.861.991.811.812.102.862.96
发展能力:
 营业收入增长率(%) -8.937.046.50-16.06-5.40-10.9138.96
 营业利润增长率(%) -16.5611.8826.06-40.032.41-10.4710.65
 税后利润增长率(%) -26.1713.4020.10-53.941.31-10.6413.06
 净资产增长率(%) 1.373.690.400.073.883.391.33
 总资产增长率(%) 15.5119.6018.8113.027.174.815.34

前瞻产业研究院